Trial intelligence / Profile preview

Intestinal disposition of mesalazine in healthy volunteers

2019-003728-19Phase 2Completed

Sponsor
KU Leuven
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of Salcrozine and esomeprazole, sponsored by KU Leuven. Started Oct 2020; status: completed.

02

Drugs

Salcrozineesomeprazole

Beyond the preview

Go deeper on 2019-003728-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-003728-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call